Irinotecan-induced immune thrombocytopenia.

AuthorsBarry C Mirtsching, James N George, Richard H Aster, Brian R Curtis
JournalThe American journal of the medical sciences (Am J Med Sci) Vol. 347 Issue 2 Pg. 167-9 (Feb 2014) ISSN: 1538-2990 [Electronic] United States
PMID24472819 (Publication Type: Case Reports, Letter, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Phytogenic
  • Bevacizumab
  • irinotecan
  • Leucovorin
  • Fluorouracil
  • Camptothecin
  • Antibodies, Monoclonal, Humanized (administration & dosage, therapeutic use)
  • Antineoplastic Agents, Phytogenic (administration & dosage, adverse effects, immunology, therapeutic use)
  • Bevacizumab
  • Camptothecin (administration & dosage, adverse effects, analogs & derivatives, immunology, therapeutic use)
  • Colonic Neoplasms (drug therapy)
  • Female
  • Fluorouracil (administration & dosage, therapeutic use)
  • Humans
  • Leucovorin (administration & dosage, therapeutic use)
  • Middle Aged
  • Platelet Count
  • Thrombocytopenia (chemically induced, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: